Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00128336
Other study ID # 03/173
Secondary ID
Status Completed
Phase Phase 3
First received August 8, 2005
Last updated May 12, 2016
Start date May 2004
Est. completion date October 2006

Study information

Verified date May 2016
Source University of Otago
Contact n/a
Is FDA regulated No
Health authority New Zealand: Food Safety Authority
Study type Interventional

Clinical Trial Summary

The purpose of this trial is to determine the most cost effective programme for overweight and obese individuals to maintain weight loss over a 2 year period.


Description:

Although short term weight loss is often achievable in overweight individuals, long term maintenance is generally poor. The researchers urgently need new information regarding the most cost effective programme(s) for maintenance of weight loss. This study will recruit 200 women and compare two approaches for providing support: one with intensive health professional support, the other peer group support facilitated by a research nurse with frequent 'weigh- ins'. The researchers will also compare two different diets one a high carbohydrate, high fibre, low glycaemic index diet versus one relatively high in monounsaturated fat and protein and low in glycaemic load.


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date October 2006
Est. primary completion date October 2006
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 25 Years to 70 Years
Eligibility Inclusion Criteria:

- Female participants

- Aged 25 to 70

- Those who have intentionally lost more than or equal to 5% of initial body weight in the previous 6 months will be recruited

- Objective evidence that volunteers were overweight or obese and have lost weight will be obtained from doctors records

Exclusion Criteria:

- Presence of major illness including cancers

- Established cardiovascular disease or stroke

- Diabetes

- Gestational diabetes

- Renal disease

- Malabsorption disorders

- Thyroid disorders

- Major psychiatric disorders

- Taking weight loss medication or medications known to cause weight gain

- Planning a pregnancy in the next 2 years

- Those who do not intend to be in the area for the next 2 years

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Intervention

Behavioral:
Lifestyle: diet and exercise intervention


Locations

Country Name City State
New Zealand Department of Human Nutrition, University of Otago Dunedin

Sponsors (2)

Lead Sponsor Collaborator
University of Otago Edgar National Centre for Diabetes Research

Country where clinical trial is conducted

New Zealand, 

Outcome

Type Measure Description Time frame Safety issue
Primary Weight 2 years No
Secondary Body composition 2 years No
Secondary Waist circumference and blood pressure 2 years No
Secondary Lipid profile and glucose and insulin 2 years No
Secondary Dietary intake 2 years No
Secondary Physical fitness 2 years No
Secondary Change in mood state 2 years No
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2